The decision by the United States to formally notify the World Health Organization (WHO) of its intent to withdraw from the multilateral body marks a significant inflection point in the history of international public health cooperation. As a founding member of the organization, the United States has long served as a cornerstone of global health initiatives, providing critical funding and scientific expertise that underpinned the successful eradication of smallpox and the substantial containment of diseases ranging from polio and HIV to Ebola and tuberculosis. The departure of such a pivotal stakeholder presents profound questions regarding the future of international health governance and the collective ability of nations to address systemic threats like antimicrobial resistance and food insecurity.
Historical Context and the Evolution of Cooperation
The relationship between the United States and the WHO spans over seven decades, beginning with the WHO’s inception in 1948. For much of this period, the U.S. was the largest contributor to the organization’s budget, playing an indispensable role in shaping global standards for medical research, vaccine deployment, and emergency response protocols. This partnership has historically functioned on the premise that a secure global health environment is a prerequisite for domestic stability and economic prosperity in the United States.
The current geopolitical friction, however, stems from divergent perspectives on the efficacy of international institutions. The U.S. government has articulated concerns regarding the WHO’s internal governance, alleging that the body has become excessively bureaucratic and susceptible to influence from nations whose interests may conflict with those of the United States. Furthermore, the U.S. has pointed to the COVID-19 pandemic as a defining failure of the organization, citing concerns over transparency and the timeliness of information sharing in the early stages of the outbreak.
Chronology of the COVID-19 Response
To evaluate these claims, a review of the early timeline of the pandemic is essential. On December 31, 2019, the WHO first received reports from China regarding a cluster of pneumonia-like cases in Wuhan. By January 1, 2020, the WHO had activated its emergency incident management system.
On January 11, 2020, following the report of the first COVID-19-related death in China, the WHO utilized its established formal channels and public media platforms to issue global alerts. By January 30, 2020, the Director-General declared a Public Health Emergency of International Concern (PHEIC), the highest alarm level under the International Health Regulations. At that juncture, fewer than 100 cases were documented outside of China, and zero deaths had been reported globally outside the epicenter. Throughout the spring of 2020, the organization repeatedly utilized phrases such as "the window of opportunity is closing" to urge member states to bolster their health infrastructure, emphasizing that the crisis was "not a drill."
Official Responses and Internal Defense
In response to allegations that the organization "concealed" failures, the WHO maintains that its guidance throughout the pandemic was based on the best available scientific evidence. The organization highlights that while it recommended evidence-based interventions—such as mask-wearing, social distancing, and vaccination—it never issued universal mandates for lockdowns or medical procedures. Instead, the WHO characterizes its role as a supportive body that provides data and technical guidance, leaving the implementation of specific restrictive policies to the discretion of sovereign governments.
Regarding the accusation that the organization is "politicized," the WHO emphasizes its status as a specialized agency of the United Nations, governed by 194 Member States. The organization maintains that its operational model is designed to ensure impartiality, operating on a consensus-driven basis that aims to serve the global population regardless of the political climate in any individual member nation.
The Financial and Structural Implications of Withdrawal
The withdrawal of the United States carries substantial implications for the operational funding of the WHO. The U.S. has historically provided a significant portion of both assessed contributions (mandatory dues) and voluntary contributions, which are earmarked for specific disease programs. A reduction in this support threatens to destabilize long-term initiatives such as the polio eradication campaign and the global monitoring of antimicrobial resistance.
Beyond finances, the loss of U.S. scientific collaboration could hinder the WHO’s ability to coordinate large-scale epidemiological studies. International health experts note that pathogen surveillance relies heavily on the cross-border flow of data; a lack of American participation could lead to silos that weaken the global early-warning system for future zoonotic threats.
Progress and Future Frameworks: The Pandemic Agreement
Despite the tension surrounding the U.S. exit, the WHO continues to move forward with legislative milestones intended to modernize global health security. Last year, member states adopted the WHO Pandemic Agreement, a landmark international instrument currently undergoing ratification. This agreement aims to create a binding legal framework for how the world responds to future pathogens.
Complementing this, member states are actively negotiating the Pathogen Access and Benefit Sharing (PABS) system. This annex to the Pandemic Agreement seeks to establish a transparent, equitable mechanism for the rapid sharing of pathogen samples and genomic data. By ensuring that the benefits—such as vaccines and therapeutics—are shared in tandem with the data, the system aims to prevent the "vaccine nationalism" that characterized much of the COVID-19 era.
Analytical Outlook
The departure of the United States from the WHO serves as a catalyst for a broader debate on the utility of international health governance in a multipolar world. Critics of the withdrawal argue that the WHO, despite its imperfections, remains the only organization with the legal mandate and technical infrastructure to coordinate a global response to a pandemic. They posit that the "politicized" nature of the organization is a reflection of the inherent difficulty of achieving consensus among 194 disparate nations, rather than an inherent failure of the WHO’s leadership.
Conversely, supporters of the U.S. position suggest that the withdrawal may prompt a necessary reform of the WHO, forcing the organization to adopt more rigorous oversight mechanisms and ensure greater accountability from its leadership. They argue that a "business as usual" approach is insufficient to address the complexities of modern global health.
The WHO Executive Board is slated to review the formal notification of withdrawal during its meeting starting on February 2, with further discussion scheduled for the World Health Assembly in May 2026. These meetings will serve as a venue for member states to reconcile their differences and potentially map a path toward the future re-engagement of the United States.
Ultimately, the WHO’s stated mission remains the achievement of the highest attainable standard of health for all people, a goal that the organization contends is fundamentally linked to global cooperation. As the international community looks toward the next potential health crisis, the absence of a founding member such as the United States necessitates a re-evaluation of how international law and medical solidarity can be maintained in an era of heightened national sovereignty and diverging strategic priorities. Whether the current path leads to a fundamental restructuring of global health or a period of fragmentation remains one of the most pressing questions in international affairs. For now, the WHO reports that it remains focused on its mandate, continuing its 24/7 monitoring of public health threats, and working with remaining member states to ensure that the infrastructure for global pandemic preparedness remains resilient.
